Max Masucci
Stock Analyst at Roth MKM
(4.00)
# 1,789
Out of 4,634 analysts
164
Total ratings
43.6%
Success rate
9.1%
Average return
Main Sectors:
Stocks Rated by Max Masucci
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDSX Biodesix | Maintained: Buy | $32 | $24.86 | +28.72% | 9 | Aug 6, 2026 | |
| TKNO Alpha Teknova | Maintained: Buy | $8 | $6.72 | +19.05% | 5 | Aug 6, 2026 | |
| XGN Exagen | Maintained: Buy | $8 → $9 | $6.64 | +35.54% | 5 | Aug 5, 2026 | |
| CSTL Castle Biosciences | Maintained: Buy | $40 | $32.35 | +23.65% | 20 | Jul 31, 2026 | |
| MASS 908 Devices | Initiated Coverage: Buy | $11 | $8.80 | +25.00% | 2 | Jul 29, 2026 | |
| BLFS BioLife Solutions | Maintained: Buy | $29 → $25 | $34.64 | n/a | 5 | Aug 9, 2023 | |
| BRKR Bruker | Maintained: Hold | $75 → $79 | $56.32 | n/a | 4 | Aug 4, 2023 | |
| RVTY Revvity | Maintained: Buy | $155 → $151 | $116.02 | n/a | 5 | Aug 2, 2023 | |
| GH Guardant Health | Maintained: Buy | $70 → $53 | $167.21 | n/a | 18 | Feb 24, 2023 | |
| CTKB Cytek Biosciences | Reiterated: Buy | $17 | $4.66 | n/a | 2 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $99 | $77.88 | n/a | 3 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $15 | $2.42 | n/a | 24 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.50 | n/a | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.86 | n/a | 2 | Sep 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.21 | n/a | 2 | Jun 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 → $100 | $318.35 | n/a | 22 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $2.08 | n/a | 1 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $39 | $1.50 | n/a | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $0.865 | n/a | 1 | Nov 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.71 | n/a | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $9.01 | n/a | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $470 → $515 | $191.79 | n/a | 16 | Jul 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 | $0.0005 | n/a | 11 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $0.25 | $0.01 | n/a | 1 | Apr 2, 2020 |
Biodesix
Aug 6, 2026
Maintained: Buy
Price Target: $32
Current: $24.86
Upside: +28.72%
Alpha Teknova
Aug 6, 2026
Maintained: Buy
Price Target: $8
Current: $6.72
Upside: +19.05%
Exagen
Aug 5, 2026
Maintained: Buy
Price Target: $8 → $9
Current: $6.64
Upside: +35.54%
Castle Biosciences
Jul 31, 2026
Maintained: Buy
Price Target: $40
Current: $32.35
Upside: +23.65%
908 Devices
Jul 29, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $8.80
Upside: +25.00%
BioLife Solutions
Aug 9, 2023
Maintained: Buy
Price Target: $29 → $25
Current: $34.64
Upside: n/a
Bruker
Aug 4, 2023
Maintained: Hold
Price Target: $75 → $79
Current: $56.32
Upside: n/a
Revvity
Aug 2, 2023
Maintained: Buy
Price Target: $155 → $151
Current: $116.02
Upside: n/a
Guardant Health
Feb 24, 2023
Maintained: Buy
Price Target: $70 → $53
Current: $167.21
Upside: n/a
Cytek Biosciences
Dec 13, 2022
Reiterated: Buy
Price Target: $17
Current: $4.66
Upside: n/a
Nov 15, 2022
Maintained: Buy
Price Target: $5 → $99
Current: $77.88
Upside: n/a
Nov 9, 2022
Maintained: Hold
Price Target: $18 → $15
Current: $2.42
Upside: n/a
Nov 3, 2022
Reiterated: Buy
Price Target: n/a
Current: $14.50
Upside: n/a
Sep 8, 2022
Reiterated: Buy
Price Target: n/a
Current: $10.86
Upside: n/a
Jun 23, 2022
Reiterated: Buy
Price Target: n/a
Current: $1.21
Upside: n/a
May 6, 2022
Maintained: Buy
Price Target: $110 → $100
Current: $318.35
Upside: n/a
Nov 29, 2021
Initiated Coverage: Buy
Price Target: $28
Current: $2.08
Upside: n/a
Nov 5, 2021
Maintained: Buy
Price Target: $32 → $39
Current: $1.50
Upside: n/a
Nov 2, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $0.865
Upside: n/a
Oct 14, 2021
Maintained: Buy
Price Target: n/a
Current: $1.71
Upside: n/a
Oct 14, 2021
Maintained: Hold
Price Target: n/a
Current: $9.01
Upside: n/a
Jul 14, 2021
Maintained: Buy
Price Target: $470 → $515
Current: $191.79
Upside: n/a
May 6, 2021
Maintained: Buy
Price Target: $3.5
Current: $0.0005
Upside: n/a
Apr 2, 2020
Initiated Coverage: Buy
Price Target: $0.25
Current: $0.01
Upside: n/a